Shots:With the noble responsibility of ensuring a healthy society on their shoulders, biopharma companies focused on Immunology are diligently working to develop treatments, vaccines, antibodies, and drugsThe global Immunology market was valued at $97.93B in 2021 and is anticipated to reach $184.21B by 2029 with a CAGR of 8.5 percent. In 2022, AbbVie…
